Observational studyBMC cancer2023

The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.

Jordane Divoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.